����������

The average premium for a benchmark plan at HealthCare.gov will decline 2% in 2021 to $379, the Centers for Medicare & Medicaid Services announced.

A study released by the Centers for Disease Control and Prevention estimates 299,028 more deaths than expected occurred in the United States between Jan. 26 and Oct. 3, with 66% attributed to COVID-19.

In a letter, AHA again urged the Center for Medicare & Medicaid Innovation to delay the start date for its new radiation oncology alternative payment model until Jan. 1, 2022.

The Department of Health and Human Services’ Office of Intergovernmental Affairs will host an Oct. 22 webinar at 1 p.m. ET on the Centers for Medicare & Medicaid Services’ recent guidance clarifying how the agency will implement its interim final rule that makes collecting and reporting COVID-19 data a condition of participation for hospitals that participate in Medicare.

On this Institute for Diversity and Health Equity webinar, 2020 AHA Carolyn Boone Lewis Equity of Care Award honorees share efforts to deliver inclusive, culturally competent care.

Congress should consider specifying in the Internal Revenue Code what services and activities it considers sufficient community benefit for tax-exempt hospitals, the Government Accountability Office said in a report.

The full U.S. Court of Appeals for the District of Columbia Circuit denied AHA’s request to reconsider two decisions from this summer that upheld the Centers for Medicare & Medicaid Services’ cuts to payments for 340B drugs and for off-campus hospital outpatient clinic visits.

The AABB, America’s Blood Centers and the American Red Cross urged eligible individuals to donate blood, calling the nation’s blood supply “critically low.”

A new analysis by Global Health 50/50, an initiative to advance gender equality in global health, sheds light on sex disparities in COVID-19 deaths.

The Department of Health and Human Services announced the new option of saliva tests at federal community-based testing sites in areas experiencing COVID-19 surge.

Jim Skogsbergh, president and CEO of Advocate Aurora Health, will join AHA Board Chair Melinda Estes, M.D., Oct. 22 at 3:30 p.m. ET to discuss COVID-19’s impact on health trends and key strategies for reimagining and innovating care during and beyond the pandemic.

COVID-19 is a pandemic with no precedent, and certainly no equal. In many ways, we’ve been learning as we go. For health care professionals, this has elevated the importance of peer-to-peer sharing as never before.

The Department of Health and Human Services announced a pair of innovation challenges aimed at improving maternal and infant health.

Access to potentially life-saving mammograms is more difficult for women who face social determinants of health such as low-income, lack of transportation or the inability to take time off from work.

A recent article on hospital field finances ignores the diverse experiences of hospitals during the pandemic, particularly those under significant financial pressure, writes Aaron Wesolowski, AHA’s vice president of policy research, analytics and strategy.

The Centers for Medicare & Medicaid Services announced Georgia can move forward with a limited Medicaid expansion plan under which enrollees up to 100% of the federal poverty level must comply with, and report, work or other qualifying activities.

The National Institutes of Health announced the start of an adaptive phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.

The Food and Drug Administration Oct. 15 said it reissued its emergency use authorization for certain, Chinese-manufactured filtering face-piece respirators that lack National Institute for Occupational Safety and Health approval.

The Food and Drug Administration Oct. 15 removed epinephrine from the lists of drugs authorized for temporary compounding during the COVID-19 public health emergency by outsourcing facilities and state-licensed pharmacies or federal facilities not registered as outsourcing facilities.

The Centers for Medicare & Medicaid Services Oct. 15 said it will incentivize labs to deliver quicker results to patients undergoing COVID-19 diagnostic testing.